Latest News about Benzinga
Recent news which mentions Benzinga
Ethereum Down More Than 3% Within 24 hours
March 27, 2024
From Benzinga
'The ELVIS Act Is Pivotal,' Says Copyleaks CEO: Tennessee's Pioneering Move In AI, Artist Rights
March 27, 2024
From Benzinga
Visa and Mastercard Reach Deal to Lower Swipe Fees, A Win for Merchants and Potential Boost for Consumer Choices: Analyst
March 27, 2024
From Benzinga
Levi Strauss To Report Q1 Earnings Next Week, Analyst Sees Gross Margin Growth, Stabilizing Wholesale Business
March 27, 2024
From Benzinga
Fidelity Includes Staking In Spot Ethereum ETF Application
March 27, 2024
From Benzinga
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years
March 27, 2024
From Benzinga
From Benzinga
From Benzinga
'Unsexy' Alternative, Operating Within Constraints, Consistency & Love: 3 Experts On Making Cannabis Businesses Self-Sustainable
March 27, 2024
From Benzinga
Largest Animal Health Firm Zoetis Hit With European Probe Over Possible Breach of Competition Rules Related To Dog Pain Medicine
March 27, 2024
From Benzinga
Can CSG Systems Become A Billion Dollar Beacon In A Crowded Tech Market? Analyst Says Yes
March 27, 2024
From Benzinga
RH Likely To Report Lower Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
March 27, 2024
From Benzinga
Technical Analysis: Spear Alpha ETF Consolidation Signals Next Break Ahead As Nvidia Trades Near All-Time Highs
March 27, 2024
From Benzinga
UPS's Strategic Investment Plan Promises Growth, But This Analyst Questions Market Performance Amid Demand Slowdown
March 27, 2024
From Benzinga
From Benzinga
Walgreens Challenges Nearly $1B Arbitration Award Over Alleged Breach of COVID-19 Test Business Contract
March 27, 2024
From Benzinga
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA's Muster, Shares Gain
March 27, 2024
From Benzinga
From Benzinga
Netflix's Ad Tier Accretion Despite Subscriber Deceleration Add To Stock Upside, Analyst Projects
March 27, 2024
From Benzinga
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
March 27, 2024
Tickers
APLS
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.